Answer
Headache was reported as an adverse reaction in 3.2% of Drovelis (drospirenone + estetrol) users.
Sources for this answer
- Drovelis 3 mg/14.2 mg film-coated tabletsGedeon Richter (UK) Ltd · emc · SmPC §4.8 Undesirable effects · Version 6Document updated
Sources checked